Human USP18 protects diverse cancer lineages from Type I Interferon independently of its canonical catalytic function (2023)

First Author: Jové V

Attributed to: Substrate Peptidomimetic Inhibitors (SPIs) of the COP9 signalosome funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2023.03.23.533924

Publication URI: http://dx.doi.org/10.1101/2023.03.23.533924

Type: Preprint